Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG1682

CLCN2 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The CLCN2 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the Raji B lymphocyte line, featuring disruption of the CLCN2 gene encoding the voltage-gated chloride channel ClC-2. This model enables study of chloride homeostasis, cell volume regulation, and apoptosis in a human Burkitt??s lymphoma background. ClC-2 is regulated by SGK1 kinase and interacts with NEDD4-2, contributing to regulatory volume decrease. Applications include patch clamp electrophysiology, cell volume measurements, flow cytometry for apoptosis, and screening of ClC-2 modulators, supporting research into channelopathies and B cell biology. For further details, contact Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    CLCN2

    Gene Identifier

    NCBI Gene ID 1181

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CLCN2 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the Raji B lymphocyte line, featuring disruption of the CLCN2 gene that encodes the voltage-gated chloride channel ClC-2. This loss-of-function model provides a tool to investigate chloride transport, cell volume regulation, and related signaling in a human Burkitt??s lymphoma context. As a polyclonal pool, it reflects genetic heterogeneity, avoiding clonal selection artifacts and enabling robust functional studies.

The Raji host cell line is an EBV-positive Burkitt??s lymphoma-derived B lymphocyte line widely used to model B cell biology and lymphomagenesis. These suspension-adapted cells maintain key pathways of humoral immune responses and are amenable to electrophysiological recordings and high-throughput applications. The EBV-driven proliferation sustains a physiological environment for studying ion channel function.

CLCN2 encodes ClC-2, a voltage-gated chloride channel activated by hyperpolarization, cell swelling, and acidic pH. SGK1 kinase phosphorylates and enhances ClC-2 activity, while NEDD4-2 ubiquitinates it for internalization. The channel interacts with HEPACAM and the actin cytoskeleton and is modulated by AMPK and PI3K/AKT signaling. Downstream, ClC-2 mediates chloride efflux for regulatory volume decrease and apoptotic volume decrease, linking cell volume homeostasis to apoptosis.

In Raji B lymphocytes, ClC-2 contributes to volume regulation during proliferation and apoptosis. Cell swelling triggers SGK1-mediated ClC-2 activation, promoting volume recovery. Disruption of CLCN2 may impair volume homeostasis and alter apoptotic sensitivity, offering insights into chloride channel roles in B cell survival and immune function. This model also aids study of ClC-2-related channelopathies such as leukoencephalopathy and epilepsy.

These knockout cells enable patch clamp analysis of chloride currents, cell volume measurements by Coulter counter, and flow cytometric apoptosis assays with Annexin V/PI. Western blot, RT-qPCR, and immunofluorescence confirm CLCN2 disruption, while chloride-sensitive dyes assess channel function. They are suitable for screening ClC-2 modulators, investigating B cell activation, and performing proliferation assays. For additional information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)